JAK1 and anaplastic large cell lymphoma: Among several oncogenic pathways, the constitutive activation of STAT3 is pathognomonic of ALK positive ALCL and it is detectable in ~50% ALK negative ALCL, as a consequence of JAK1/STAT3 mutations or aberrant cytokine receptor signalling [21].